Potential of the FES–hERL PET reporter gene system — Basic evaluation for gene therapy monitoring
- 31 January 2006
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (1) , 145-151
- https://doi.org/10.1016/j.nucmedbio.2005.07.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Successes and risks of gene therapy in primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2004
- Therapeutic angiogenesis for myocardial ischemiaExpert Review of Cardiovascular Therapy, 2004
- In Vivo Quantitative Noninvasive Imaging of Gene Transfer by Single-Photon Emission Computerized TomographyHuman Gene Therapy, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Adenovirus Biodistribution and Noninvasive Imaging of Gene Expression In Vivo by Positron Emission Tomography Using Human Sodium/Iodide Symporter as Reporter GeneHuman Gene Therapy, 2002
- VEGF Gene Delivery for Treatment of Ischemic Cardiovascular DiseaseTrends in Cardiovascular Medicine, 2002
- Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transductionGene Therapy, 2001
- A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomographyProceedings of the National Academy of Sciences, 2000
- Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animalsGene Therapy, 1999
- Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomographyProceedings of the National Academy of Sciences, 1999